All four are in order, fastest above slowest — every timeframe pointing the same way.
CONMED Corporation
Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.
The base has run 76.4 weeks and fell 49% from its ceiling at its deepest. The pivot is $61.08, and the stock closed 19.2% below it. Its relative strength rating is 70.
Its industry has too few members to make an index of, so it is read against the S&P 500 and can only be turning, caution or unconfirmed.
Nothing dated in the next three months that we can ingest automatically.
On average 5.0% either way across its last 8 reports.
Checking your subscription…
Close before the report day to close after it, so it holds whether the company reported before the open or after the close.
No figures in US GAAP filings for this company. Most foreign listings report under international standards, which this does not read.
Held by 2 of 46 tracked funds at the end of Q3 2026.
Last quarter: 1 bought new, 1 trimmed.
Checking your subscription…
From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.
From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.
Headlines link to the publisher. We do not host, summarise or rank them, and a headline appearing here is not a view about the company.
Nobody bought or sold on the open market in the last 6 months. There were 8 filings for awards, option exercises or shares withheld to pay tax — those happen on a vesting schedule, so they are not a decision to buy or sell.
From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.
5 of 9 published checks currently line up. This is a count, not a probability — nothing on this site measures how often a setup works.
These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.
Checking your subscription…
No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.